Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders. Evolent’s Class A common stock is listed on the New York Stock Exchange under the symbol “EVH.”
Based in Arlington, Virginia, Evolent Health partners with health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent Health helps physicians and health systems achieve superior quality and cost results.
The Davis Polk corporate team included partner Richard D. Truesdell Jr. and associates Yasin Keshvargar, John H. Runne and Joshua S. Sills. The tax team included partner Mary Conway and associates Isaac MacDonald and Caroline E. Dayton. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.